In vitro and in vivo antibacterial activities of S-4661, a new carbapenem

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 1, 1998, Pages 94-99

  Tsuji, Masakatsu ^a,b   Ishii, Yoshikazu ^a   Ohno, Akira ^a   Miyazaki, Shuichi ^a   Yamaguchi, Keizo ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIAPENEM; CARBAPENEM DERIVATIVE; CEFPIROME; CEFTAZIDIME; DORIPENEM; IMIPENEM; MEROPENEM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENCY; ENTEROBACTERIACEAE; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; IN VIVO STUDY; LUNG INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031973491     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.1.94     Document Type: Article

References (14)

1. Edwards, J. R. 1995. Meropenem: a microbiological overview. J. Antimicrob. Chemother. 36(Suppl. A):1-17.
2. Iso, Y. T. Irie, Y. Nishino, K. Motokawa, and Y. Nishitani. 1996. A novel 1β-methylcarbapenem antibiotic, S-4661: synthesis and structure-activity relationships of 2-(5-substituted pyrrolidin-3-ylthio)-1β-methlycarbapenems. J. Antibiot. (Tokyo) 49:199-209.
3. Japanese Society for Chemotherapy. 1993. Method for the determination of minimum inhibitory concentration (MIC) of fastidious bacteria and anaerobic bacteria by microdilution method. Chemotherapy (Tokyo) 41:183-189.
4. Japanese Society for Chemotherapy. 1990. Method for the determination of minimum inhibitory concentration (MIC) of aerobic bacteria by microbrothdilution method. Chemotherapy (Tokyo) 38:102-105.
5. Kahan, J. S., F. M. Kahan, R. Geogelman, S. A. Currie, M. Jacson, E. O. Stapley, A. K. Miller, D. Hendlin, S. Mochales, S. Hernandez, H. B. Woodruff, and J. Birnbaum. 1979. Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation, and physical properties. J. Antibiot. (Tokyo) 32:1-12.
6. Kimura, Y., K. Murakami, H. Onoue, J. Shimada, and S. Kuwahara. 1994. S-4661, a new carbapenem: III. Pharmacokinetics in laboratory animals, abstr. F37, p. 32. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
7. Kimura, Y., M. Nakano, and T. Yoshida. 1987. Microbiological assay methods for 6315-S (flomoxef) concentrations in body fluid. Chemotherapy 35(Suppl. 1):129-136.
8. Miller, L. C., and M. L. Tainter. 1944. Estimation of the ED50 and its error by means of logarithmic probit graph paper. Proc. Soc. Exp. Biol. Med. 57:261-264.
9. National Committee for Clinical Laboratory Standards. 1990. Approved standards M7-A2. Method for dilution antibacterial susceptibility tests for bacteria that grow aerobically, 2nd ed. National Committee for Clinical Laboratory Standards, Villanova, Pa.
10. Shimada, J., and Y. Kawahara. 1994. Overview of a new carbapenem, panipenem/betamipron. Drugs Exp. Clin. Res. 20:241-245.
11. Sunagawa, M., H. Matsumura, T. Inoue, M. Fukasawa, and M. Kato. 1990. A novel carbapenem antibiotic, SM-7338: structure-activity relationships. J. Antibiot. (Tokyo) 43:519-532.
12. Tateda, K., K. Takashima, H. Miyazaki, T. Matsumoto, T. Hatori, and K. Yamaguchi. 1996. Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model. Antimicrob. Agents Chemother. 40:1520-1525.
13. Tsuji, M., Y. Ishii, A. Ohno, S. Miyazaki, and K. Yamaguchi. 1995. In vitro and in vivo antibacterial activities of S-1090, a new oral cephalosporin. Antimicrob. Agents Chemother. 39:2544-2551.
14. Ubukata, K., M. Hikida, M. Yoshida, K. Nishiki, Y. Furukawa, K. Tashiro, M. Konno, and S. Mitsuhashi. 1990. In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I. Antimicrob. Agents Chemother. 34:994-1000.